Mankind Pharma
-
{
- All
- News
-
Mankind Pharma Share Price Falls Over 5% Even As Q1 Profit Rises 29%
Mankind Pharma reported a 29% rise in June-quarter profit and revenue above Rs 4,000 crore, but its shares fell more than 5% after the earnings announcement
-
Laurus Labs, Biocon, Rubicon Lead Motilal Oswal’s Top Picks As Q3 Healthcare Outlook Brightens — Check Details
Q3 Healthcare Results Preview: Motilal Oswal sees strong Q3 for Laurus Labs, Biocon; hospitals to drive sector momentum
-
Stocks To Buy: Sun Pharma, Cipla, Rainbow Among Systematix Top Picks In Healthcare Space Post Q2 Results
Systematix’s top picks for the sector include Sun Pharma, Cipla, Ajanta Pharma among others - Check full list.
-
LIC, Mankind Pharma, Aurobindo Pharma, Godrej Properties, Birlasoft, Metropolis, Symphony & More Q2 Review
HDFC Securities recommends 'Add' rating for LIC, Aurobindo Pharma, Star Cement, Metropolis, Godrej Properties 'Buy' Symphony, Astral, 'Reduce' Alkyl Amines, Clean Science - here's why
-
Jefferies Keeps Mankind Pharma Among Top Picks Despite Q2 Setback — Check Revised Target Price
Jefferies has trimmed the target price of Mankind Pharma citing a slower-than-expected recovery in its reorganisation efforts.
-
Stock Picks Today: LIC, Crompton, Mankind Pharma, Devyani International, Eternal On Brokerage Radar
Analysts have tweaked share price targets after these companies announced their September quarter results.
-
Dealing Room Buzz: Bajaj Finance, Bajaj Housing, Airtel, Mankind Pharma, Hindalco, Muthoot Finance, IRCTC
This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Bajaj Finance, Bajaj Housing, Bharti Airtel, Mankind Pharma, Hindalco, Muthoot Finance and IRCTC.
-
Mankind Pharma Confident GLP-1 Won't Dent Anti-Diabetic Portfolio Growth
Even if shifts occur within the anti-diabetes segment, such as therapies moving from the top to the bottom of the market pyramid, Mankind expects to remain stable.
-
Tata Steel, Cholamandalam, PB Fintech, Mankind Pharma, Godrej Properties, Thermax, Symphony & More Q1 Review
Read HDFC Securities Q1 results review on Greenpanel, Aptus Value, Aarti Industries
-
Coal India, Chalet Hotels, Mankind Pharma, JSW Energy, Eicher Motors Shares React To Q1 Results
Teamlease Services Ltd., City Union Bank Ltd., Chambal Fertilizers and Chemicals Ltd. and Eicher Motors Ltd. were trading higher.
-
Mankind Pharma Q1 Results: Profit Declines 18%, Revenue Up 25%; Interim Dividend Declared
The board of Mankind Pharma approved the payment of an interim dividend of Re 1 at a face value of Re 1 each for the fiscal 2026.
-
Mankind Pharma Q1 Results Preview: Revenue Likely To Rise, Net Profit May Decline
As per Bloomberg estimates, Mankind Pharma's consolidated revenue for the first quarter is expected to rise year-on-year to Rs 3,605.53 crore.
-
Buy, Sell Or Hold: Mankind Pharma, Varun Beverages, Mahindra Lifespace, BHEL, Inox Wind — Ask Profit
Market analysts also shared buy, sell and hold recommendations for stocks like Bajaj Housing Finance.
-
Sun Pharma, Cipla And More — Nirmal Bang's Top Stock Picks In Pharma Pack; Q1 Results Preview
Nirmal Bang expects Ajanta Pharma, Dr. Reddy's, JB Chemicals, Eris, Sun Pharma, and Lupin to outperform the IPM.
-
Mankind Pharma Gets Target Price Hike — Why Jefferies Calls It Top Pick
Jefferies anticipates that the first and second quarters will be pivotal for Mankind Pharma, with India Rx growth normalising in the second half of the fiscal.
-
Mankind Pharma Share Price Falls Over 5% Even As Q1 Profit Rises 29%
Mankind Pharma reported a 29% rise in June-quarter profit and revenue above Rs 4,000 crore, but its shares fell more than 5% after the earnings announcement
-
Laurus Labs, Biocon, Rubicon Lead Motilal Oswal’s Top Picks As Q3 Healthcare Outlook Brightens — Check Details
Q3 Healthcare Results Preview: Motilal Oswal sees strong Q3 for Laurus Labs, Biocon; hospitals to drive sector momentum
-
Stocks To Buy: Sun Pharma, Cipla, Rainbow Among Systematix Top Picks In Healthcare Space Post Q2 Results
Systematix’s top picks for the sector include Sun Pharma, Cipla, Ajanta Pharma among others - Check full list.
-
LIC, Mankind Pharma, Aurobindo Pharma, Godrej Properties, Birlasoft, Metropolis, Symphony & More Q2 Review
HDFC Securities recommends 'Add' rating for LIC, Aurobindo Pharma, Star Cement, Metropolis, Godrej Properties 'Buy' Symphony, Astral, 'Reduce' Alkyl Amines, Clean Science - here's why
-
Jefferies Keeps Mankind Pharma Among Top Picks Despite Q2 Setback — Check Revised Target Price
Jefferies has trimmed the target price of Mankind Pharma citing a slower-than-expected recovery in its reorganisation efforts.
-
Stock Picks Today: LIC, Crompton, Mankind Pharma, Devyani International, Eternal On Brokerage Radar
Analysts have tweaked share price targets after these companies announced their September quarter results.
-
Dealing Room Buzz: Bajaj Finance, Bajaj Housing, Airtel, Mankind Pharma, Hindalco, Muthoot Finance, IRCTC
This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Bajaj Finance, Bajaj Housing, Bharti Airtel, Mankind Pharma, Hindalco, Muthoot Finance and IRCTC.
-
Mankind Pharma Confident GLP-1 Won't Dent Anti-Diabetic Portfolio Growth
Even if shifts occur within the anti-diabetes segment, such as therapies moving from the top to the bottom of the market pyramid, Mankind expects to remain stable.
-
Tata Steel, Cholamandalam, PB Fintech, Mankind Pharma, Godrej Properties, Thermax, Symphony & More Q1 Review
Read HDFC Securities Q1 results review on Greenpanel, Aptus Value, Aarti Industries
-
Coal India, Chalet Hotels, Mankind Pharma, JSW Energy, Eicher Motors Shares React To Q1 Results
Teamlease Services Ltd., City Union Bank Ltd., Chambal Fertilizers and Chemicals Ltd. and Eicher Motors Ltd. were trading higher.
-
Mankind Pharma Q1 Results: Profit Declines 18%, Revenue Up 25%; Interim Dividend Declared
The board of Mankind Pharma approved the payment of an interim dividend of Re 1 at a face value of Re 1 each for the fiscal 2026.
-
Mankind Pharma Q1 Results Preview: Revenue Likely To Rise, Net Profit May Decline
As per Bloomberg estimates, Mankind Pharma's consolidated revenue for the first quarter is expected to rise year-on-year to Rs 3,605.53 crore.
-
Buy, Sell Or Hold: Mankind Pharma, Varun Beverages, Mahindra Lifespace, BHEL, Inox Wind — Ask Profit
Market analysts also shared buy, sell and hold recommendations for stocks like Bajaj Housing Finance.
-
Sun Pharma, Cipla And More — Nirmal Bang's Top Stock Picks In Pharma Pack; Q1 Results Preview
Nirmal Bang expects Ajanta Pharma, Dr. Reddy's, JB Chemicals, Eris, Sun Pharma, and Lupin to outperform the IPM.
-
Mankind Pharma Gets Target Price Hike — Why Jefferies Calls It Top Pick
Jefferies anticipates that the first and second quarters will be pivotal for Mankind Pharma, with India Rx growth normalising in the second half of the fiscal.
